We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.98%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$106B
AUM Growth
+$6.52B
Cap. Flow
+$4.41B
Cap. Flow %
4.14%
Top 10 Hldgs %
13.68%
Holding
3,236
New
179
Increased
2,227
Reduced
440
Closed
133

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$115M
2
AAPL icon
Apple
AAPL
+$95.4M
3
DXC icon
DXC Technology
DXC
+$91M
4
PFE icon
Pfizer
PFE
+$66.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$60.4M

Sector Composition

Rank Sector Weight
1 Technology 14.68%
2 Financials 14.59%
3 Healthcare 13.17%
4 Industrials 11.08%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADVM
3101
DELISTED
Adverum Biotechnologies
ADVM
-2,821
Closed -$77K
ALT icon
3102
Altimmune
ALT
$568M
-331
Closed -$81K
AMSC icon
3103
American Superconductor
AMSC
$1.29B
-19,200
Closed -$132K
APVO icon
3104
Aptevo Therapeutics
APVO
$4.96M
0
-$62K
AXSM icon
3105
Axsome Therapeutics
AXSM
$11.7B
-17,700
Closed -$70K
CDTX
3106
DELISTED
Cidara Therapeutics
CDTX
-858
Closed -$134K
CRDF icon
3107
Cardiff Oncology
CRDF
$63M
-491
Closed -$41K
DWSN icon
3108
Dawson Geophysical
DWSN
$131M
-34,020
Closed -$181K
DXLG icon
3109
Destination XL Group
DXLG
$32.4M
-56,400
Closed -$161K
ELDN icon
3110
Eledon Pharmaceuticals
ELDN
$255M
-93
Closed -$13K
FCEL icon
3111
FuelCell Energy
FCEL
$1.45B
-151
Closed -$75K
GLOB icon
3112
Globant
GLOB
$1.65B
-39,851
Closed -$1.45M
CBIO
3113
Crescent Biopharma
CBIO
$544M
-196
Closed -$107K
GSM icon
3114
FerroAtlántica
GSM
$589M
-108,500
Closed -$1.12M
HYG icon
3115
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
-4,115
Closed -$362K
IMUX icon
3116
Immunic
IMUX
$177M
-90
Closed -$144K
IRIX icon
3117
IRIDEX
IRIX
$15M
-12,100
Closed -$144K
IWM icon
3118
iShares Russell 2000 ETF
IWM
$79.2B
-6,054
Closed -$833K
JAKK icon
3119
Jakks Pacific
JAKK
$304M
-2,330
Closed -$129K
LFVN icon
3120
LifeVantage
LFVN
$80M
-21,200
Closed -$114K
LPCN icon
3121
Lipocine
LPCN
$17.3M
-1,535
Closed -$102K
LRMR icon
3122
Larimar Therapeutics
LRMR
$377M
-3,714
Closed -$208K
MCHX icon
3123
Marchex
MCHX
$78M
-48,200
Closed -$132K
PARAA
3124
DELISTED
Paramount Global Class A
PARAA
-3,600
Closed -$254K
QNST icon
3125
QuinStreet
QNST
$926M
-44,900
Closed -$176K

Similar funds

Charles Schwab's Q2 2017 Portfolio in Review

As of Q2 2017, Charles Schwab held 3,236 positions worth $106B, up 6.5% from $99.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $4.41B of net new capital in Q2 2017, opening 179 new positions and adding to 2,227 existing holdings. Its largest new stake was DXC Technology: 1,371,360 shares worth $91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was HP, an estimated $50.3M trimmed.

  • Charles Schwab's largest Q2 2017 buy was DXC Technology: 1,371,360 shares worth $91M.
  • Charles Schwab added most to ExxonMobil in Q2 2017, an estimated $115M increase.
  • Charles Schwab's biggest Q2 2017 reduction was HP, cutting an estimated $50.3M.
  • Charles Schwab fully exited Yahoo Inc in Q2 2017, selling an estimated $121M.
  • Charles Schwab's ten largest holdings make up 14% of its $106B portfolio in Q2 2017.
  • Charles Schwab opened 179 new positions and closed 133 in Q2 2017.
  • Charles Schwab's portfolio value rose 6.5% quarter-over-quarter to $106B.

Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.